Study to Evaluate the Care Process and the Quality of STEMI Care

NCT02961777 | Completed DMC

• 1 other identifier: CP4ACS\2013\2
• Study Type: observational
• Target: 640
• Locations: 0 countries
• Sites: N/A

Brief Summary

Cardiovascular diseases, and more precisely patients with ST - elevated myocardial infarction are globally responsible for a large number of hospitalizations and deaths. Monitoring the quality of care for these patients is very relevant topic. Investigators developed indicators from the scientific literature on the quality of care for patients with STEMI at both the patient level and hospital level. The indicators were subsequently validated by a RAND modified Delphi - study of multidisciplinary experts in the care of patients with STEMI. In this study, the following objectives are set:

1. 1.) Study of the quality of care for patients with STEMI in 16 Flemish hospitals with cardiology department by retrospective and prospective audit of 20 patient records per participating hospital .
2. 2.) Study of the interdisciplinary relationships and communication within teams involved in the care of patients with STEMI in the participating hospitals 3) Study of perceived organization of care for patients with STEMI in the participating hospitals
3. 3.) A retrospective observational audit of 20 patient records of patients with STEMI each participating hospital.
4. 4.) A prospective observational audit of 20 patient records of patients with STEMI each participating hospital.
5. 5.) A survey using validated instruments of interdisciplinary relationships and communication on the one hand and on the other by the teams involved in the care of patients with STEMI perceived organization of care .

Conditions

Myocardial Infarction; Acute Coronary Syndrome

Outcome Measures

Primary Outcomes (2)

• performance on quality indicators at patient level as defined by the CP4ACS Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium (NCT02030210)

  This study evaluates quality indicators at patient level as defined by the CP4ACS Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium. The study is limited to the period in which the patients are hospitalized; No data is gathered before or after hospitalization.

  through study completion, an average of 1 year

• performance on quality indicators at hospital level as defined by the CP4ACS Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium (NCT02030210)

  This study evaluates quality indicators at hospital level as defined by the CP4ACS Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium. The study is limited to the period in which the patients are hospitalized. No data is gathered before or after hospitalization.

  through study completion, an average of 1 year

Study Arms (3)

Time 1

retrospective evaluation of patient record. no intervention

Time 2

retrospective evaluation of patient record. no intervention

Other: implementation of care pathway

Time 3

retrospective evaluation of patient record. no intervention

Other: implementation of care pathway

Interventions

implementation of care pathway OTHER

implementation of a care pathway

Time 2; Time 3

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

patients admitted with STEMI within 24 hours after symptom onset and eligble for reperfusion according to ESC STEMI guidelines

You may qualify if:

• patients admitted with STEMI within 24 hours after symptom onset and
• eligible for reperfusion according to ESC STEMI guidelines

Sponsors & Collaborators

• European Pathway Association: lead
• KU Leuven: collaborator
• Universitaire Ziekenhuizen KU Leuven: collaborator

MeSH Terms

Conditions

Myocardial Infarction; Acute Coronary Syndrome

Condition Hierarchy (Ancestors)

Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Infarction; Ischemia; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Necrosis

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Month
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: November 2, 2016
• First Posted: November 11, 2016
• Study Start: January 1, 2014
• Primary Completion: December 1, 2017
• Study Completion: January 1, 2018
• Last Updated: July 24, 2018

Record last verified: 2018-07

Data Sharing

• IPD Sharing: Will not share